Exelixis, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersAlameda, CA
SAM.gov UEIR47FPKTS9T63
Brands
An exceptional employee experience
Accelerating impact in oncology
Row of test tubesThis company sells these brands.
Exelixis develops medicines for cancer treatment, with a focus on oncology. The company conducts research and development, clinical trials, and has investigational therapies in its pipeline, including a therapy for metastatic colorectal cancer that has a U.S. FDA PDUFA date set for December 2026.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Exelixis, INC. | Alameda | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


